Skip to main content

Table 10 Decision matrix

From: A computational approach to drug design for multiple sclerosis via QSPR modeling, chemical graph theory, and multi-criteria decision analysis

Alternatives

ReZG1

ReZG2

SO

ABC

mMsde

ISDD

Cladribine

19

24.6

76.84

14.65

26.08

9.3769

Teriflunomide

18

19.3

65.79

13.5

25.43

7.1551

Mitoxantrone

27.5

38.5

115.12

47.35

39.11

15.7692

Masitinib

36

45.6

137.03

28.49

47.59

18.4769

Fingolimod

10

8.3

28.05

6.58

12.19

3.7462

Dimethyl Fumarate

21

21.8

68.75

7.55

26.01

9.3398

Laquinimood

25

31.4

95.47

19.23

30.16

10.7077

Diroximel Fumarate

18

19.1

59.92

13.08

22.92

7.8307

Siponimod

35.5

42.7

133.45

27.41

47.36

16.8705

Ozanimod

30

38

113.74

23.31

38.89

15.2846

Ponesimod

31.5

36.6

110.51

23.46

39.59

15.0615

Cyclophosphamide

14

14.9

46.72

10

17.26

6.2383